Nate Stasko

Dr. Stasko joined Vast following his role as Senior Strategic Advisor to parent company, KnowBio LLC where he was an originator of the entrepreneurial vision to develop and optimize a proprietary chemistry platform that enables the delivery of nitric oxide across multiple therapeutic areas. As President & CEO of Novan Inc., an early embodiment of this vision, he led Novan through financings totaling more than $150 million, award of government grants and contracts totaling $15 million, and a successful initial public offering in September 2016 to become a NASDAQ listed company (NOVN).